TC
IBB icon

Tatro Capital’s iShares Biotechnology ETF IBB Stock Holding History

Tatro Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,165
Closed -$682K – 98
2021
Q2 		$682K Buy
4,165
+302
+8% +$46.5K 0.47% 41
2021
Q1 		$582K Sell
3,863
-4,118
-52% -$654K 0.45% 42
2020
Q4 		$1.21M Sell
7,981
-250
-3% -$35.7K 1.13% 19
2020
Q3 		$1.11M Buy
8,231
+1,050
+15% +$142K 1.27% 17
2020
Q2 		$982K Buy
+7,181
New +$915K 1.41% 19

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Tatro Capital's IBB Position: Q3 2021 in Review

Tatro Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2021, closing a stake of 4,165 shares — an estimated $682K sold.

Tatro Capital first reported a position in IBB in Q2 2020 and held it in 5 quarters. The position peaked at $1.21M in Q4 2020. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

  • Tatro Capital reported no remaining iShares Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
  • Tatro Capital sold 4,165 iShares Biotechnology ETF shares in Q3 2021, an estimated $682K.
  • Tatro Capital first reported a position in iShares Biotechnology ETF in Q2 2020 and held it in 5 quarters.
  • Tatro Capital's iShares Biotechnology ETF position peaked at $1.21M in Q4 2020.
  • 855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Tatro Capital's 13F filing for Q3 2021, filed 22 Oct 2021.